RELAPSED/REFRACTORY MULTIPLE MYELOMA
Clinical trials for RELAPSED/REFRACTORY MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Four-Pronged attack on stubborn blood cancer tested
Disease control TerminatedThis study tested a combination of four medications for people with multiple myeloma that has come back or stopped responding to prior treatments. The goal was to see how well the combination worked and how safe it was. The trial was stopped early and enrolled 23 participants.
Matched conditions: RELAPSED/REFRACTORY MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Early trial tests new drug for Tough-to-Treat blood cancer
Disease control TerminatedThis early-stage study tested a new drug called AMG 701, both alone and combined with other medications, for adults with multiple myeloma that had returned or stopped responding to many prior treatments. The main goals were to find a safe and effective dose and to see how the bod…
Matched conditions: RELAPSED/REFRACTORY MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC